NCT05137704View on ClinicalTrials.gov

A Study on the Use of Healthcare Resources and Costs of Attention Deficit Hyperactivity Disorder (ADHD) in Adults in England

CompletedOBSERVATIONAL
Enrollment

2,236

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

March 31, 2022

Study Completion Date

March 31, 2022

Conditions
Attention Deficit Hyperactivity Disorder (ADHD)
Interventions
OTHER

No intervention

This is a non-interventional study.

Trial Locations (1)

N19JY

IQVIA Ltd, London

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT05137704 - A Study on the Use of Healthcare Resources and Costs of Attention Deficit Hyperactivity Disorder (ADHD) in Adults in England | Biotech Hunter | Biotech Hunter